Search

Author/Creator Pandya, Shuchi

1. ACTR-31. PHASE 1 STUDY OF AG-881, AN INHIBITOR OF MUTANT IDH1 AND IDH2: RESULTS FROM THE RECURRENT/PROGRESSIVE GLIOMA POPULATION. (5th November 2018)

Authors:
Mellinghoff, Ingo; Penas-Prado, Marta; Peters, Katherine; Cloughesy, Timothy; Burris, Howard; Maher, Elizabeth; Janku, Filip; Cote, Gregory; De La Fuente, Macarena; Clarke, Jennifer; Steelman, Lori; Le, Kha; Xu, Huansheng; Sonderfan, Alison; Hummel, Diana; Schoenfeld, Steven; Yen, Katharine; Pand...
Journal:
Neuro-oncology
Issue:
Volume 20(2018)Supplement 6
Page Start:
vi18
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. RTID-05. INDIGO: A GLOBAL, RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF VORASIDENIB (AG-881) VS PLACEBO IN PATIENTS WITH RESIDUAL/RECURRENT GRADE II GLIOMA WITH AN ISOCITRATE DEHYDROGENASE 1/2 (IDH1/2) MUTATION. (9th November 2020)

Authors:
Mellinghoff, Ingo; van den Bent, Martin; Clarke, Jennifer; Maher, Elizabeth; Peters, Katherine; Touat, Mehdi; de Groot, John; De La Fuente, Macarena; Arrillaga-Romany, Isabel; Wick, Wolfgang; Ellingson, Benjamin; Schoenfeld, Steven; Liu, Hua; Le, Kha; Lu, Min; Steelman, Lori; Hassan, Islam; Pandy...
Journal:
Neuro-oncology
Issue:
Volume 22(2020)Supplement 2
Page Start:
ii194
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗